Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2003
10/30/2003CA2466229A1 Use of il-19, il-22 and il-24 to treat hematopoietic disorders
10/29/2003EP1357120A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
10/29/2003EP1357115A1 Alkanoic acid derivatives, process for their production and use thereof
10/29/2003EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
10/29/2003EP1357104A1 Tropolone derivative
10/29/2003EP1356816A1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
10/29/2003EP1356815A1 Analgesic and antiinflammatory drugs
10/29/2003EP1356810A1 TNFa PRODUCTION INHIBITORS
10/29/2003EP1356287A2 Replication assay for detecting anti-viral substances
10/29/2003EP1356277A2 Method for altering cell fate
10/29/2003EP1356276A2 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action
10/29/2003EP1356097A2 The anti-neoplastic agent et-743 inhibits trans activation by sxr
10/29/2003EP1356091A2 Method of detecting inflammatory lung disorders
10/29/2003EP1356085A2 Identification of modulators of dham-kinase and inflammatory diseases
10/29/2003EP1356079A2 Srebp pathway modulation through targeting hisrs
10/29/2003EP1356071A2 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356053A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/29/2003EP1356036A2 Process and compositions for peptide, protein and peptidomimetic synthesis
10/29/2003EP1356032A2 Human kinases
10/29/2003EP1355949A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto
10/29/2003EP1355945A2 Flint glycoforms
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355940A2 Urotensin-ii agonists and antagonists
10/29/2003EP1355928A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
10/29/2003EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355916A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/29/2003EP1355910A1 Formulation of boronic acid compounds
10/29/2003EP1355909A2 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355904A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003EP1355903A1 Pyrazole derivatives against tgf overexpression
10/29/2003EP1355902A1 Sulfonamide compounds, their preparation and use
10/29/2003EP1355900A2 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003EP1355899A1 Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
10/29/2003EP1355894A1 Amidinophenylalanine derivatives as thrombin inhibitors
10/29/2003EP1355892A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors
10/29/2003EP1355891A2 Therapy
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355885A1 Pyridine derivatives useful as cyclooxygenase inhibitor
10/29/2003EP1355878A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355698A2 Insulin receptor activators for the treatment of metabolic disorders in humans resulting from treatment of hiv infection with hiv protease inhibitors
10/29/2003EP1355673A2 Multivalent meningococcal polysaccharide-protein conjugate vaccine
10/29/2003EP1355670A2 Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane destabilisers
10/29/2003EP1355668A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355665A2 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/29/2003EP1355658A1 Pyk2 phosphorylation by her3 induces tumor invasion
10/29/2003EP1355650A1 New combination of active ingredients containing alfuzosine and apomorphine
10/29/2003EP1355646A1 Muscarinic receptor agonists
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1355644A2 The use of substituted azetidinone compounds for the treatment of sitosterolemia
10/29/2003EP1355643A2 Epoxyvibsanin b
10/29/2003EP1355642A2 INHIBITION OF NF-(k)B BY TRITERPENE COMPOSITIONS
10/29/2003EP1355635A1 New film coating
10/29/2003EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/29/2003EP1355588A2 Delivery of therapeutic capable agents
10/29/2003EP1251853B1 Transdermal therapeutic system for the administration of zaleplon
10/29/2003EP1235787B1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
10/29/2003EP1214302B1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors
10/29/2003EP1169316B9 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/29/2003EP1140047B1 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
10/29/2003EP1094834B1 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
10/29/2003EP1077935B1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors
10/29/2003EP1032265B1 New psoralens for pathogen inactivation
10/29/2003EP0996728B1 IMPROVED ANTI-IgE ANTIBODIES AND METHODS OF IMPROVING ANTIBODIES
10/29/2003EP0994711B1 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function
10/29/2003EP0983272B1 A new class of benzoporphyrin derivative photoactive compounds
10/29/2003EP0951553B1 Adenovirus e4 proteins for inducing cell death
10/29/2003EP0923566B1 High molecular weight polymer-based prodrugs
10/29/2003EP0546118B1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
10/29/2003CN1452634A HLA binding peptides and their uses
10/29/2003CN1452633A Mammalian genes, related reagent and methods
10/29/2003CN1452630A Substd. sapogenins and their use
10/29/2003CN1452628A 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds
10/29/2003CN1452627A 3'-prodrugs of 2'-deoxy-beta-L-nucleosides
10/29/2003CN1452620A Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation
10/29/2003CN1452610A Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system
10/29/2003CN1452596A Method and apparatus for producing high functional water contg. titanium
10/29/2003CN1452497A Combinations of SSRI and estrogenic agents
10/29/2003CN1452496A Use of strains of parapox ovis virus against organ fibrosis
10/29/2003CN1452494A Use of secretin-receptorl igands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1452490A Composition and method for intervening neuronal death using sulfasalazine
10/29/2003CN1452486A Pharmaceutical composition and use method
10/29/2003CN1452485A Cannabinoid drugs
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451747A Medusa cystatin gene, and expression and use thereof
10/29/2003CN1451656A Novel salt of perindopril and pharmaceutical composition contg. same
10/29/2003CN1451417A Process for preparing novel form of ease pill
10/29/2003CN1451416A Process for preparing novel form of coptidis bolus for clearing away heat of upper part of body
10/29/2003CN1451412A Refreshing tobacco and mustard chewing tablet
10/29/2003CN1451399A Superfine gastrodia tuber and American ginseng powder buccal lozenge
10/29/2003CN1451389A Agent for promoting cell activation for external use
1 ... 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 ... 1564